STOCK TITAN

Applied Optoelectronics, Inc. 424B Filings

AAOI NASDAQ

Every 424B that Applied Optoelectronics, Inc. (AAOI) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 424B covers the supplement that carries the terms of a priced offering, so if you follow AAOI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AAOI filings page.

Rhea-AI Summary

Applied Optoelectronics, Inc. (AAOI) has established an at-the-market equity program to issue and sell up to $600,000,000 of its common stock from time to time through Raymond James & Associates, Inc. and Needham & Company, LLC as sales agents. The shares may be sold on The Nasdaq Global Market or through other permitted methods at market-related prices.

The agents will receive up to 2.0% of the gross sales price as commissions. AAOI had 84,906,289 shares outstanding as of August 20, 2026. Assuming all $600 million is sold at $129.10 per share (the August 20, 2026 last sale price), net tangible book value per share would rise from $19.72 to about $26.20, implying immediate dilution of approximately $102.90 per share to new investors.

AAOI currently intends to use any net proceeds for general corporate purposes, including debt repayment, working capital, capital expenditures and potential acquisitions. The number of shares actually sold, if any, and the timing of sales will depend on market conditions and company directives; there is no minimum sale requirement.

Rhea-AI Summary

Applied Optoelectronics, Inc. filed a prospectus supplement to offer shares of common stock having an aggregate offering price of up to $600,000,000 through an at-the-market equity distribution agreement with Raymond James and Needham.

The company may sell shares from time to time at market prices through the Nasdaq Global Market or other permitted methods. The prospectus states 80,242,767 shares outstanding as of May 13, 2026 and discloses a last reported sale price of $223.10 per share on that date. Proceeds are to be used for general corporate purposes, which may include debt repayment, working capital, capital expenditures and acquisitions.

Rhea-AI Summary

Applied Optoelectronics, Inc. amends its prospectus supplement to increase the size of an at-the-market equity program to permit the sale of up to $500,000,000 of common stock.

The amendment states that 2,476,307 shares have been sold for gross proceeds of approximately $249,999,983 under the sales agreement as of March 12, 2026, and that the company may sell additional shares for an aggregate offering price of approximately $250,000,017 through agents Raymond James and Needham. The shares will be offered from time to time in “at-the-market” offerings and the agents may receive commissions of up to 2.0%.

Rhea-AI Summary

Applied Optoelectronics, Inc. is offering up to $250,000,000 of its common stock in an at-the-market equity program through Raymond James and Needham as agents.

The sales may occur from time to time on Nasdaq or in other permitted transactions; agents may receive commissions up to 2.0%. Shares outstanding were 75,198,817 as of February 25, 2026. The prospectus supplement illustrates an example issuance of 4,301,446 shares at an assumed price of $58.12 for aggregate gross proceeds of approximately $250,000,000, and shows illustrative dilution to new investors of $45.85 per share. The company intends to use net proceeds for general corporate purposes, including debt repayment, working capital, capital expenditures, and possible acquisitions.

Rhea-AI Summary

Applied Optoelectronics, Inc. (AAOI) launched an at‑the‑market offering of up to $180,000,000 of common stock through Raymond James and Needham as sales agents. Shares may be sold from time to time on Nasdaq or in other permitted transactions, with the Agents using commercially reasonable efforts and no obligation to sell a specific amount.

The company will pay up to 2.0% sales commissions and intends to use net proceeds for general corporate purposes, including debt repayment, working capital, capital expenditures and potential acquisitions. There is no escrow arrangement. As context, 68,279,888 shares were outstanding as of November 6, 2025.

The supplement includes an illustrative dilution scenario at a $29.10 share price and outlines standard ATM distribution methods and risk factors, including pricing variability and potential dilution from future financings and equity awards.